Business Matters: Eclipsed by Catastrophe

November 15, 2001
G. Steven Burrill

Chief Executive Officer at Burrill & Company

BioPharm International, BioPharm International-11-01-2001, Volume 14, Issue 11

by G. Steven Burrill at Burrill & Company Despite stimulating and positive news for biotech product approvals and high-value deals this quarter, market performance has been shaped by the terrorist attacks and their aftermath.